SCHEMBL25828606

SCHEMBL25828606

CC(=O)CN(CCOC(C)=O)C(C)=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.40
CHRM5 P08912 3/20 0.39
CHRM1 P11229 3/20 0.39
CHRM3 P20309 3/20 0.39
CHRM2 P08172 2/20 0.39
CHRM4 P08173 2/20 0.39
CHRNB2 P17787 2/20 0.39
CHRNA4 P43681 2/20 0.39
PGR P06401 1/20 0.39
HTR1A P08908 1/20 0.39
TBXA2R P21731 1/20 0.39
CHRNB4 P30926 1/20 0.39
CHRNA3 P32297 1/20 0.39
CHRNA7 P36544 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CHRNA10 Q9GZZ6 1/20 0.39
CHRNA9 Q9UGM1 1/20 0.39
TSHR P16473 1/20 0.39
GALR3 O60755 2/20 0.38
GAA P10253 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28645748 0.86 ALDH1A1 (0.39) ALDH1A1CHRM5CHRM1CHRM3CHRM2
SCHEMBL26300313 0.82 TSHR (0.38) ALDH1A1CHRM5CHRM1CHRM3CHRM2
SCHEMBL22345272 0.82 CHRM5 (0.36) ALDH1A1CHRM5CHRM1CHRM3CHRM2
SCHEMBL24967165 0.82 ALDH1A1 (0.39) ALDH1A1CHRM5CHRM1CHRM3CHRM2
SCHEMBL10620663 0.81 ALDH1A1 (0.35) ALDH1A1CHRM5CHRM1CHRM3CHRM2
SCHEMBL15233097 0.81 MLYCD (0.35) ALDH1A1SMN1; SMN2TSHRGAARAB9A
SCHEMBL11929073 0.81 ALDH1A1 (0.46) ALDH1A1CHRM5CHRM1CHRM3CHRM2
SCHEMBL12542180 0.79 CHRM5 (0.34) ALDH1A1CHRM5CHRM1CHRM3CHRM2
SCHEMBL9884588 0.78 CHRM5 (0.46) ALDH1A1CHRM5CHRM1CHRM3CHRM2
SCHEMBL26292675 0.78 CHRM5 (0.33) ALDH1A1CHRM5CHRM1CHRM3CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023018471-A9 PIPERAZINE-BASED AGONISTS OF LFA-1 AND VLA-4 TEXAS HEART INSTITUTE (US) 2023-07-13 WO disclosed